PRX-302（Prazer Therapeutics）

N/A

Report date: 2023/05/17 08:51:38

Base Information

Drug NamePRX-302（Prazer Therapeutics）
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionMicrotubule-associated protein tau modulators
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrazer Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrazer Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A